UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Analytical and bioanalytical chemistry, ISSN 1618-2642, 9/2019, Volume 411, Issue 22, pp. 5659 - 5668
Biochemistry, general | Food Science | MALDI mass spectrometry imaging | Niemann-pick disease type C | Laboratory Medicine | Cholesterol | Chemistry | Analytical Chemistry | Monitoring/Environmental Analysis | Ganglioside | Ceramide | Characterization and Evaluation of Materials | Apoptosis | Biochemistry & Molecular Biology | Physical Sciences | Life Sciences & Biomedicine | Biochemical Research Methods | Chemistry, Analytical | Science & Technology | Animals | Ceramides - metabolism | Gangliosides - metabolism | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization - methods | Mice | Chromatography, Liquid - methods | Intracellular Signaling Peptides and Proteins - genetics | Tandem Mass Spectrometry - methods | Cerebellum - pathology | Mice, Knockout | Cerebellum | Niemann-Pick disease | Pattern formation | Spectroscopy | Ions | Lipids | Mass spectroscopy | Mapping | Sphingolipids | Ganglioside GM1 | Substantia alba | Negative ions | Cell death | Neurodegeneration | Ionization | Imaging | Biomolecules | Npc1 protein | Scientific imaging | Degeneration | Localization | Mass spectrometry | Gangliosides | Index Medicus
Journal Article
Molecular neurobiology, ISSN 0893-7648, 4/2016, Volume 53, Issue 3, pp. 1824 - 1842
Neurology | Neurosciences | GM1 Chemistry and Physico-chemistry | GM1 and the neurodegenerative diseases | Biomedicine | Neurobiology | GM1 | GM1 and Cholera toxin | Cellular organization of GM1 | Cell Biology | Neurotrophic and neuroprotective properties of GM1 | GM1 and GBS | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neuroprotective Agents - therapeutic use | Animals | Neuroprotective Agents - pharmacology | Cholera Toxin - metabolism | Humans | Terminology as Topic | G(M1) Ganglioside - therapeutic use | G(M1) Ganglioside - chemistry | Neurodegenerative Diseases - drug therapy | G(M1) Ganglioside - metabolism | G(M1) Ganglioside - pharmacology | Autoimmunity | Nervous system diseases | Autoantibodies | Cholera | Cholera toxin | Gangliosides | Organic acids | Brain | Biochemistry | Cellular biology | Neurons | Index Medicus
Journal Article
Biochimica et biophysica acta. Biomembranes, ISSN 0005-2736, 08/2020, Volume 1862, Issue 8, pp. 183233 - 183233
Journal Article
Frontiers in neuroscience, ISSN 1662-4548, 02/2018, Volume 12, pp. 45 - 45
GM1 ganglioside | B4GALNT1 | Glial cell-derived neurotrophic factor | Parkinson's disease | GDNF | Alpha-synuclein | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Cellular signal transduction | Research | Lipid metabolism | Gangliosides | Enzymes | Glial cell line-derived neurotrophic factor | Basal ganglia | Neurodegenerative diseases | Neurons | Substantia nigra | Parkinsons disease | Central nervous system diseases | Ganglioside GM1 | Synuclein | Metabolism | Kinases | Studies | Proteins | Pathology | Hypotheses | Overexpression | Neostriatum | Constipation | Movement disorders | Apoptosis | alpha-synuclein | glial cell-derived neurotrophic factor
Journal Article
The Journal of infectious diseases, ISSN 0022-1899, 7/2008, Volume 198, Issue 2, pp. 226 - 233
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) | Infectious diseases | Applied microbiology | Biological and medical sciences | Medical sciences | DNA, Bacterial - isolation & purification | Humans | Influenza Vaccines - adverse effects | Gangliosidosis, GM1 - immunology | Gangliosides - immunology | Mice, Inbred C3H | Hemagglutination Inhibition Tests | Animals | Campylobacter jejuni - immunology | Guillain-Barre Syndrome - immunology | Swine | Glycolipids - immunology | Polymerase Chain Reaction | Antibody Formation | Influenza A virus - immunology | Mice | Porcine Reproductive and Respiratory Syndrome - immunology | Campylobacter jejuni - genetics | Influenza vaccines | Guillain-Barre syndrome | Anti-antibodies | Physiological aspects | Development and progression | Research | Gangliosides | Identification and classification | Index Medicus | Abridged Index Medicus
Journal Article
Scientific reports, ISSN 2045-2322, 12/2019, Volume 9, Issue 1, pp. 8362 - 8362
Journal Article
Journal of the neurological sciences, ISSN 0022-510X, 2012, Volume 324, Issue 1, pp. 140 - 148
Neurology | GM1 | Parkinson's disease | Treatment | Symptomatic | Ganglioside | Disease modification | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Biological and medical sciences | Medical sciences | Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases | G(M1) Ganglioside - adverse effects | Double-Blind Method | Follow-Up Studies | Humans | Middle Aged | Dopamine Agonists - therapeutic use | G(M1) Ganglioside - therapeutic use | Male | Treatment Outcome | Parkinson Disease - drug therapy | Disease Progression | Antiparkinson Agents - therapeutic use | Neuropsychological Tests | Analysis of Variance | Female | Gangliosides | Care and treatment | Index Medicus | Disease Modification | Parkinson’s disease
Journal Article